Mark McDade insider trades: Tourmaline Bio (TRML) stock buys and sales
Trades on the price chart
Daily close, with an arrow on each day they bought or sold
Companies
Where Mark reports to the SEC
and 6 more companies
Open-market buys and sales
30 trades reported on SEC Form 4, newest first
| Date | Stock | Type | Shares | Price | Value | Holding | Reported |
|---|---|---|---|---|---|---|---|
| Jan 29, 2024 | TRML | ↑ Buy | 100,000 | $32.50 | $3.3M | By Qiming U.S. Healthcare Fund III,L.P. | Jan 31, 2024 (2d) |
| Jan 27, 2023 | JSPR | ↑ Buy | 2,666,666 | $1.50 | $4.0M | Direct | Apr 11, 2023 (74d) |
| Apr 1, 2022 | ICVX | ↑ Buy | 42,225 | $7.10 | $300K | Direct | Apr 5, 2022 (4d) |
| Aug 2, 2021 | ICVX | ↑ Buy | 221,351 | $15.00 | $3.3M | Direct | Aug 2, 2021 (0d) |
| Aug 11, 2015 | AIMT | ↑ Buy | 16,660 | $16.00 | $267K | Direct | Aug 11, 2015 (0d) |
| Jul 17, 2015 | N | ↑ Buy | 422 | $22.50 | $9K | Direct | Jul 17, 2015 (0d) |
| May 6, 2015 | N | ↑ Buy | 422 | $22.50 | $9K | Direct | May 8, 2015 (2d) |
| Jan 17, 2007 | PDLI | ↓ Sell | 10,000 | $21.45 | $215K | Direct | Jan 19, 2007 (2d) |
| Jan 16, 2007 | PDLI | ↓ Sell | 10,000 | $21.29 | $213K | Direct | Jan 18, 2007 (2d) |
| Jan 12, 2007 | PDLI | ↓ Sell | 10,000 | $20.89 | $209K | Direct | Jan 17, 2007 (5d) |
| Jan 11, 2007 | PDLI | ↓ Sell | 9,000 | $20.71 | $186K | Direct | Jan 16, 2007 (5d) |
| Jan 11, 2007 | PDLI | ↓ Sell | 1,000 | $20.66 | $21K | Direct | Jan 16, 2007 (5d) |
| Jan 10, 2007 | PDLI | ↓ Sell | 9,943 | $20.41 | $203K | Direct | Jan 12, 2007 (2d) |
| Jan 10, 2007 | PDLI | ↓ Sell | 57 | $20.37 | $1K | Direct | Jan 12, 2007 (2d) |
| Jan 9, 2007 | PDLI | ↓ Sell | 20,000 | $20.36 | $407K | Direct | Jan 10, 2007 (1d) |
| Jan 5, 2007 | PDLI | ↓ Sell | 8,500 | $20.29 | $172K | Direct | Jan 9, 2007 (4d) |
| Jan 5, 2007 | PDLI | ↓ Sell | 1,500 | $20.25 | $30K | Direct | Jan 9, 2007 (4d) |
| Jan 4, 2007 | PDLI | ↓ Sell | 18,698 | $20.30 | $380K | Direct | Jan 4, 2007 (0d) |
| Jan 3, 2007 | PDLI | ↓ Sell | 1,302 | $20.26 | $26K | Direct | Jan 4, 2007 (1d) |
| Jan 17, 2006 | PDLI | ↓ Sell | 10,000 | $28.02 | $280K | Direct | Jan 19, 2006 (2d) |
| Jan 13, 2006 | PDLI | ↓ Sell | 10,000 | $28.29 | $283K | Direct | Jan 17, 2006 (4d) |
| Jan 12, 2006 | PDLI | ↓ Sell | 10,000 | $29.26 | $293K | Direct | Jan 17, 2006 (5d) |
| Jan 11, 2006 | PDLI | ↓ Sell | 10,000 | $29.93 | $299K | Direct | Jan 13, 2006 (2d) |
| Jan 10, 2006 | PDLI | ↓ Sell | 10,000 | $31.29 | $313K | Direct | Jan 12, 2006 (2d) |
| Jan 9, 2006 | PDLI | ↓ Sell | 10,000 | $30.51 | $305K | Direct | Jan 11, 2006 (2d) |
| Jan 6, 2006 | PDLI | ↓ Sell | 10,000 | $30.10 | $301K | Direct | Jan 10, 2006 (4d) |
| Jan 5, 2006 | PDLI | ↓ Sell | 10,000 | $29.72 | $297K | Direct | Jan 9, 2006 (4d) |
| Jan 4, 2006 | PDLI | ↓ Sell | 10,000 | $28.70 | $287K | Direct | Jan 6, 2006 (2d) |
| Jan 3, 2006 | PDLI | ↓ Sell | 10,000 | $28.01 | $280K | Direct | Jan 5, 2006 (2d) |
| Jun 20, 2005 | PDLI | ↓ Sell | 10,000 | $20.00 | $200K | Direct | Jun 22, 2005 (2d) |
Each row is one filing's trades in one stock, summed. Shares and prices are as filed, before any later stock split.
About Mark McDade's insider trades
Mark McDade is an insider at Tourmaline Bio (TRML). Since Jun 20, 2005, Mark has reported 7 open-market purchases worth $11.2M and 23 sales worth $5.2M on SEC Form 4. There have been no open-market trades in the last 12 months.
Their filings also include grants and awards (33 filings), option exercises (22 filings), shares returned to the company (6 filings), other transactions (3 filings). These aren't open-market trades and aren't counted above.
How to read insider trades
Officers, directors and owners of more than 10% of a company must report trades in its stock on SEC Form 4, usually within two business days. Purchases with their own money are the stronger signal: insiders sell for many reasons (taxes, diversification, a house), but buy for one. See every TRML insider trade, the latest insider trades across the market, or cluster buys, when several insiders buy the same stock within days.